Literature DB >> 7911022

CD26: a surface protease involved in T-cell activation.

B Fleischer1.   

Abstract

CD26 is a proteolytic enzyme (dipeptidylpeptidase IV) with a wide tissue distribution and a unique specificity. Recent developments indicate that CD26 is a multifunctional molecule that may have important functions in the immune system. Here, Bernhard Fleischer reviews the current knowledge of CD26 and discusses the possible functions of this molecule in T lymphocytes.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7911022     DOI： 10.1016/0167-5699(94)90316-6

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  42 in total

1.  Antigen presentation of Type II collagen in rats.

Authors:  B Catchpole; N A Staines; A S Hamblin
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

2.  Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase.

Authors:  M Hegen; J Kameoka; R P Dong; S F Schlossman; C Morimoto
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

3.  Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.

Authors:  Sen Shi; Swayam Prakash Srivastava; Megumi Kanasaki; Jianhua He; Munehiro Kitada; Takako Nagai; Kyoko Nitta; Susumu Takagi; Keizo Kanasaki; Daisuke Koya
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

4.  Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells.

Authors:  D Reinhold; U Bank; F Bühling; U Lendeckel; J Faust; K Neubert; S Ansorge
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

5.  Regulation of the gene for human dipeptidyl peptidase IV by hepatocyte nuclear factor 1 alpha.

Authors:  R H Erickson; J R Gum; C D Lotterman; J W Hicks; R S Lai; Y S Kim
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

6.  Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients.

Authors:  Miguel Cuchacovich; Héctor Gatica; Paula Vial; Jorge Yovanovich; Salvatore V Pizzo; Mario Gonzalez-Gronow
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

7.  Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis.

Authors:  A M Abu El-Asrar; S Struyf; S A Al-Kharashi; L Missotten; J Van Damme; K Geboes
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

8.  CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells.

Authors:  Kei Ohnuma; Tadanori Yamochi; Masahiko Uchiyama; Kunika Nishibashi; Satoshi Iwata; Osamu Hosono; Hiroshi Kawasaki; Hirotoshi Tanaka; Nam H Dang; Chikao Morimoto
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection.

Authors:  Daisuke Katagiri; Yoshifumi Hamasaki; Kent Doi; Koji Okamoto; Kousuke Negishi; Masaomi Nangaku; Eisei Noiri
Journal:  J Am Soc Nephrol       Date:  2013-10-03       Impact factor: 10.121

Review 10.  T-cell activation via CD26 and caveolin-1 in rheumatoid synovium.

Authors:  Kei Ohnuma; Hiroshi Inoue; Masahiko Uchiyama; Tadanori Yamochi; Osamu Hosono; Nam H Dang; Chikao Morimoto
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.